Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-21-000492
Filing Date
2021-06-04
Accepted
2021-06-04 16:58:38
Documents
2
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3901
2 POA attachment_1.htm EX-24 3127
  Complete submission text file 0001192482-21-000492.txt   8497
Mailing Address C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address
O'Brien Federica F. (Reporting) CIK: 0001140119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39130 | Film No.: 21997172

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Issuer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus